Standout Papers

Marginal Structural Models and Causal Inference in Epidemiology 2000 2026 2008 2017 3.8k
  1. Marginal Structural Models and Causal Inference in Epidemiology (2000)
    James M. Robins, Miguel A. Hernán et al. Epidemiology
  2. Constructing Inverse Probability Weights for Marginal Structural Models (2008)
    Stephen R. Cole, Miguel A. Hernán American Journal of Epidemiology
  3. A Structural Approach to Selection Bias (2004)
    Miguel A. Hernán, Sonia Hernández–Dı́az et al. Epidemiology
  4. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting (2021)
    Noa Dagan, Noam Barda et al. New England Journal of Medicine
  5. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1. (2016)
    Miguel A. Hernán, James M. Robins American Journal of Epidemiology
  6. Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men (2000)
    Miguel A. Hernán, Babette Brumback et al. Epidemiology
  7. Causal Knowledge as a Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology (2002)
    Miguel A. Hernán American Journal of Epidemiology
  8. The Hazards of Hazard Ratios (2009)
    Miguel A. Hernán Epidemiology
  9. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study (2002)
    Hyon K. Choi, Miguel A. Hernán et al. The Lancet
  10. Vitamin D intake and incidence of multiple sclerosis (2004)
    Kassandra L. Munger, S. M. Zhang et al. Neurology
  11. Estimating causal effects from epidemiological data (2006)
    Miguel A. Hernán et al. Journal of Epidemiology & Community Health
  12. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting (2021)
    Noam Barda, Noa Dagan et al. New England Journal of Medicine
  13. Instruments for Causal Inference (2006)
    Miguel A. Hernán, James M. Robins Epidemiology
  14. Adjusted survival curves with inverse probability weights (2003)
    Stephen R. Cole, Miguel A. Hernán Computer Methods and Programs in Biomedicine
  15. Activated Injectable Vitamin D and Hemodialysis Survival (2005)
    Ming Teng, Myles Wolf et al. Journal of the American Society of Nephrology
  16. A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease (2002)
    Miguel A. Hernán, Bahi Takkouche et al. Annals of Neurology
  17. Observational Studies Analyzed Like Randomized Experiments (2008)
    Miguel A. Hernán, Álvaro Alonso et al. Epidemiology
  18. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study (2021)
    Noam Barda, Noa Dagan et al. The Lancet
  19. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses (2016)
    Miguel A. Hernán, Brian C. Sauer et al. Journal of Clinical Epidemiology
  20. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women (2001)
    Alberto Ascherio, Shumin M. Zhang et al. Annals of Neurology
  21. Temporal trends in the incidence of multiple sclerosis (2008)
    Álvaro Alonso, Miguel A. Hernán Neurology
  22. Per-Protocol Analyses of Pragmatic Trials (2017)
    Miguel A. Hernán, James M. Robins New England Journal of Medicine
  23. Target Trial Emulation (2022)
    Miguel A. Hernán, Wei Wang et al. JAMA
  24. The C-Word: Scientific Euphemisms Do Not Improve Causal Inference From Observational Data (2018)
    Miguel A. Hernán American Journal of Public Health
  25. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy (2021)
    Noa Dagan, Noam Barda et al. Nature Medicine
  26. Methods of Public Health Research — Strengthening Causal Inference from Observational Data (2021)
    Miguel A. Hernán New England Journal of Medicine
  27. The Target Trial Framework for Causal Inference From Observational Data: Why and When Is It Helpful? (2025)
    Miguel A. Hernán, Issa J Dahabreh et al. Annals of Internal Medicine

Immediate Impact

6 by Nobel laureates 14 from Science/Nature 79 standout
Sub-graph 1 of 21

Citing Papers

Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
2022 StandoutScience
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
2022 StandoutScience

Works of Miguel A. Hernán being referenced

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
2021 Standout
The continuing uncertainty about cancer risk in inflammatory bowel disease
2016

Author Peers

Author Last Decade Papers Cites
Miguel A. Hernán 8793 5560 5612 309 40.5k
Patrick Royston 5774 4284 1740 267 50.1k
Sander Greenland 7981 4272 1894 337 42.5k
Nan M. Laird 7802 2802 1904 234 67.0k
Jonathan A C Sterne 2892 4024 6911 380 80.4k
Peter C. Austin 6142 9426 2156 895 72.2k
Stephen R. Cole 3820 2015 3283 445 22.5k
Ian R. White 5132 3188 989 440 41.9k
Kenneth F. Schulz 3745 8270 2290 210 98.9k
Karel G.M. Moons 2812 4121 1458 467 51.8k
Simon G. Thompson 2648 3145 2486 217 88.5k

All Works

Loading papers...

Rankless by CCL
2026